Murphy J L, Wootton S A, Bond S A, Jackson A A
Department of Human Nutrition, University of Southampton.
Arch Dis Child. 1991 Apr;66(4):495-500. doi: 10.1136/adc.66.4.495.
Stool energy losses and the sources of energy within the stool were determined in 20 healthy controls and 20 patients with cystic fibrosis while on their habitual pancreatic enzyme replacement treatment. Stool energy losses were equivalent to 3.5% of gross energy intake in healthy children (range 1.3-5.8%). Despite a comparable gross energy intake, stool energy losses were three times greater in patients with cystic fibrosis than controls averaging 10.6% of gross energy intake (range 4.9-19.7%). Stool lipid could account for only 29% and 41% of the energy within the stool in controls and patients with cystic fibrosis respectively and was poorly related to stool energy. Approximately 30% of the energy within the stool could be attributable to colonic bacteria in both the healthy children and patients with cystic fibrosis. These results suggest that stool energy losses in healthy children are relatively modest but that even when patients with cystic fibrosis are symptomatically well controlled on pancreatic enzyme replacement, raised stool energy losses may continue to contribute towards an energy deficit sufficient to limit growth in cystic fibrosis. As the energy content per gram wet weight remains relatively constant (8 kJ/g), stool energy losses may be estimated from simple measurements of stool wet weight.
在20名健康对照者和20名接受常规胰酶替代治疗的囊性纤维化患者中,测定了粪便能量损失及粪便中的能量来源。健康儿童的粪便能量损失相当于总能量摄入的3.5%(范围为1.3 - 5.8%)。尽管总能量摄入相当,但囊性纤维化患者的粪便能量损失是对照组的三倍,平均占总能量摄入的10.6%(范围为4.9 - 19.7%)。在对照组和囊性纤维化患者中,粪便脂质分别仅占粪便中能量的29%和41%,且与粪便能量关系不大。在健康儿童和囊性纤维化患者中,粪便中约30%的能量可归因于结肠细菌。这些结果表明,健康儿童的粪便能量损失相对较小,但即使囊性纤维化患者在胰酶替代治疗下症状得到良好控制,粪便能量损失增加仍可能导致能量不足,足以限制囊性纤维化患者的生长。由于每克湿重的能量含量相对恒定(8千焦/克),粪便能量损失可通过简单测量粪便湿重进行估算。